Ado-trastuzumab emtansine approved for advanced breast cancer.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

Volumn 70, Issue 7, 2013, Pages 562-

  Traynor, Kate ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERBB2 PROTEIN, HUMAN; MAYTANSINE; MONOCLONAL ANTIBODY; TRASTUZUMAB EMTANSINE;

BREAST TUMOR; DRUG APPROVAL; FEMALE; FOOD AND DRUG ADMINISTRATION; GENETICS; HUMAN; NOTE; UNITED STATES;

ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; DRUG APPROVAL; FEMALE; HUMANS; MAYTANSINE; RECEPTOR, ERBB-2; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

MLCS; MLOWN;

EID: 84884487002     PISSN: None     EISSN: 15352900     Source Type: None    
DOI: 10.2146/news130023     Document Type: Note

References (0)